Furthermore, we demonstrate that PGRMC1 and TMEM97 expression are associated with an increased risk of tumor recurrence within the first 5 years following breast cancer diagnosis, in a manner that seems to be mediated by their association with cellular proliferation. Here, PGRMC1 is linked to breast carcinoma.